[go: up one dir, main page]

MXPA02001923A - Radiopharmaceutical products and their preparation procedure. - Google Patents

Radiopharmaceutical products and their preparation procedure.

Info

Publication number
MXPA02001923A
MXPA02001923A MXPA02001923A MXPA02001923A MXPA02001923A MX PA02001923 A MXPA02001923 A MX PA02001923A MX PA02001923 A MXPA02001923 A MX PA02001923A MX PA02001923 A MXPA02001923 A MX PA02001923A MX PA02001923 A MXPA02001923 A MX PA02001923A
Authority
MX
Mexico
Prior art keywords
preparation procedure
radiopharmaceutical products
radiopharmaceutical
products
procedure
Prior art date
Application number
MXPA02001923A
Other languages
Spanish (es)
Inventor
Emmanuel Bellande
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of MXPA02001923A publication Critical patent/MXPA02001923A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/06Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA02001923A 1999-09-01 2000-08-23 Radiopharmaceutical products and their preparation procedure. MXPA02001923A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910970A FR2797769B1 (en) 1999-09-01 1999-09-01 RADIOPHARMACEUTICAL PRODUCTS AND THEIR PREPARATION PROCESS
PCT/IB2000/001161 WO2001015746A1 (en) 1999-09-01 2000-08-23 Radiopharmaceutical products and their preparation procedure

Publications (1)

Publication Number Publication Date
MXPA02001923A true MXPA02001923A (en) 2003-07-21

Family

ID=9549465

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02001923A MXPA02001923A (en) 1999-09-01 2000-08-23 Radiopharmaceutical products and their preparation procedure.

Country Status (23)

Country Link
EP (1) EP1210127A1 (en)
JP (1) JP2003508455A (en)
KR (1) KR20020040799A (en)
CN (1) CN1371292A (en)
AU (1) AU6463100A (en)
BG (1) BG106438A (en)
BR (1) BR0013729A (en)
CA (1) CA2383517A1 (en)
CZ (1) CZ2002782A3 (en)
EA (1) EA200200307A1 (en)
EE (1) EE200200105A (en)
FR (1) FR2797769B1 (en)
HK (1) HK1044893A1 (en)
HU (1) HUP0202714A2 (en)
IL (1) IL148076A0 (en)
MX (1) MXPA02001923A (en)
NO (1) NO20021001L (en)
NZ (1) NZ517377A (en)
PL (1) PL353803A1 (en)
SK (1) SK2772002A3 (en)
WO (1) WO2001015746A1 (en)
YU (1) YU14202A (en)
ZA (1) ZA200201057B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094369B2 (en) 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7131997B2 (en) 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7053134B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7449236B2 (en) 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7588825B2 (en) 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US7501179B2 (en) 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
FR2919189A1 (en) * 2007-07-26 2009-01-30 Cyclopharma Sa Lab NOVEL COMPOSITIONS BASED ON POLYOSIDES GRAFTED BY POLYAMINE OR POLYSOUFRE COMPOUNDS.
CN102977174B (en) * 2012-12-19 2015-04-22 北京师范大学 99mTc(CO)3 nuclear-labeled macrocyclic polyamine triazole ring glucosyl complex and its preparation method and application
PL240772B1 (en) 2018-06-11 2022-06-06 Nanothea Spolka Akcyjna Method of producing polymer nanoparticles chelating radioactive isotopes for use in diagnostics and treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7412164L (en) * 1974-09-27 1976-03-29 Pharmacia Ab FUNDS FOR INTRAVASCULAR ADMINISTRATION
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
ES2199226T3 (en) * 1992-09-04 2004-02-16 The General Hospital Corporation BIOCOMPATIBLE POLYMERS CONTAINING DIAGNOSTIC OR THERAPEUTIC HALVES.
US5958372A (en) * 1994-06-28 1999-09-28 Nycomed Imaging As Low viscosity chelating polymers for diagnostic imaging
FR2736834B1 (en) * 1995-07-17 1997-08-29 Cis Bio Int RADIOPHARMACEUTICAL PRODUCTS WITH CARDIAC TROPISM COMPRISING A NITRURO COMPLEX OF A TRANSITIONAL METAL AND HAVING FAST MYOCARDIAL CLEARANCE

Also Published As

Publication number Publication date
NO20021001D0 (en) 2002-02-28
CA2383517A1 (en) 2001-03-08
PL353803A1 (en) 2003-12-01
FR2797769B1 (en) 2003-07-25
FR2797769A1 (en) 2001-03-02
IL148076A0 (en) 2002-09-12
NZ517377A (en) 2003-08-29
SK2772002A3 (en) 2002-09-10
WO2001015746A1 (en) 2001-03-08
HK1044893A1 (en) 2002-11-08
ZA200201057B (en) 2003-07-30
BG106438A (en) 2002-09-30
HUP0202714A2 (en) 2002-12-28
EE200200105A (en) 2003-04-15
CZ2002782A3 (en) 2002-08-14
CN1371292A (en) 2002-09-25
KR20020040799A (en) 2002-05-30
JP2003508455A (en) 2003-03-04
BR0013729A (en) 2002-05-07
EP1210127A1 (en) 2002-06-05
NO20021001L (en) 2002-04-11
YU14202A (en) 2004-09-03
AU6463100A (en) 2001-03-26
EA200200307A1 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
ZA200201057B (en) Radiopharmaceutical products and their preparation procedure.
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
SG87776A1 (en) Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
CZ20011518A3 (en) Pharmaceutical preparation
GB2355194B (en) Coformulation methods and their products
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
PL343512A1 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
ZA200104280B (en) Pharmaceutical combination preparations.
HUP0203735A3 (en) 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
SI1043307T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
GB9802088D0 (en) Pharmaceutical products
IL120554A (en) Kombucha products and processes for the preparation thereof
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
HRP20010951A2 (en) Pharmaceutical complex
SI1043306T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
HUP0203678A3 (en) Nitro-sulfobenzamide-derivatives, preparation and use thereof
ZA200109571B (en) Novel compounds, their use and preparation.
ZA99168B (en) Pharmaceutical formulations and processes for their preparation.
HUP0203455A3 (en) 2-arylquinoline derivatives, preparation and therautic use thereof
GB9914202D0 (en) Products and methods
GB9912059D0 (en) Products and methods
GB9917273D0 (en) Products and methods
HUP0201140A3 (en) 3-deoxy-desmycosin derivatives and their preparation

Legal Events

Date Code Title Description
FA Abandonment or withdrawal